Cargando…

Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial

IMPORTANCE: The increasing HIV incidence rates and suboptimal rates of testing, engagement, and retention in care for people who inject drugs (PWID) in Kazakhstan underscore the need for effective HIV care continuum interventions for PWID. OBJECTIVE: To determine the effectiveness of the Bridge HIV...

Descripción completa

Detalles Bibliográficos
Autores principales: El-Bassel, Nabila, McCrimmon, Tara, Wu, Elwin, Chang, Mingway, Terlikbayeva, Assel, Hunt, Timothy, Darisheva, Meruyert, Primbetova, Sholpan, Davis, Alissa, Metsch, Lisa R., Feaster, Daniel J., Baiserkin, Baurzhan, Abishev, Asylkhan, Denebayeva, Alfiya, Sagimbayev, Beibit, Kurmetova, Kulpan, Mashirov, Kozhakhmet, Gilbert, Louisa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Medical Association 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716389/
https://www.ncbi.nlm.nih.gov/pubmed/36454567
http://dx.doi.org/10.1001/jamanetworkopen.2022.44734
_version_ 1784842678762995712
author El-Bassel, Nabila
McCrimmon, Tara
Wu, Elwin
Chang, Mingway
Terlikbayeva, Assel
Hunt, Timothy
Darisheva, Meruyert
Primbetova, Sholpan
Davis, Alissa
Metsch, Lisa R.
Feaster, Daniel J.
Baiserkin, Baurzhan
Abishev, Asylkhan
Denebayeva, Alfiya
Sagimbayev, Beibit
Kurmetova, Kulpan
Mashirov, Kozhakhmet
Gilbert, Louisa
author_facet El-Bassel, Nabila
McCrimmon, Tara
Wu, Elwin
Chang, Mingway
Terlikbayeva, Assel
Hunt, Timothy
Darisheva, Meruyert
Primbetova, Sholpan
Davis, Alissa
Metsch, Lisa R.
Feaster, Daniel J.
Baiserkin, Baurzhan
Abishev, Asylkhan
Denebayeva, Alfiya
Sagimbayev, Beibit
Kurmetova, Kulpan
Mashirov, Kozhakhmet
Gilbert, Louisa
author_sort El-Bassel, Nabila
collection PubMed
description IMPORTANCE: The increasing HIV incidence rates and suboptimal rates of testing, engagement, and retention in care for people who inject drugs (PWID) in Kazakhstan underscore the need for effective HIV care continuum interventions for PWID. OBJECTIVE: To determine the effectiveness of the Bridge HIV care continuum intervention implemented in needle and syringe programs (NSPs) in Kazakhstan. DESIGN, SETTING, AND PARTICIPANTS: This stepped-wedge cluster trial was conducted from February 2017 to May 2020, with implementation beginning sequentially across 3 cities (Almaty, Karaganda-Temirtau, and Shymkent) in August 2017, January 2018, and May 2019. Intervention effect sizes were estimated via population-averaged models, and hypothesis testing relied on a permutation testing approach. The primary unit of analysis was an NSP. Data analysis was performed from October 2020 to April 2022. INTERVENTIONS: The intervention addresses the full HIV care continuum: identification, testing, referral to services, and linkage to HIV care. The 3 intervention components were (1) a social network strategy, a peer-driven recruitment approach for HIV testing; (2) HIV counseling, rapid testing, and referral following international and national guidelines and protocols; and (3) enhanced antiretroviral treatment and access to services. MAIN OUTCOMES AND MEASURES: The primary outcomes were the effectiveness of implementing Bridge’s enhanced service integration approach in increasing the number of PWID served at NSPs, increasing the number of PWID who are tested for HIV in NSPs, and improving linking HIV-positive PWID with HIV care. Secondary outcomes included numbers of clients registered for HIV care, initiation of antiretroviral therapy, and viral suppression. RESULTS: Twenty-four NSPs (8 in each city) served a total of 1225 PWID (369 in Almaty, 618 in Karaganda-Temirtau, and 238 in Shymkent) at the preimplementation study step; 1015 clients (82.9%) were male, and the mean (SD) age was 36.7 (7.1) years. Compared with preimplementation study steps, during Bridge intervention implementation steps, NSPs experienced a significant increase in the number of PWID clients registered (incidence rate ratio, 2.37; 95% CI, 1.48-3.78) and the number of PWID who received rapid HIV tests (incidence rate ratio, 3.98; 95% CI, 2.30-6.90). No significant increase in referral to HIV care was observed. The study also found significant support for secondary outcomes of antiretroviral therapy initiation and the number of clients who achieved viral suppression. CONCLUSIONS AND RELEVANCE: In this stepped-wedge cluster trial, the findings suggest that implementation of the Bridge intervention was associated with significant improvement in several steps in the continuum of HIV care for PWID in Kazakhstan. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02796027
format Online
Article
Text
id pubmed-9716389
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Medical Association
record_format MEDLINE/PubMed
spelling pubmed-97163892022-12-22 Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial El-Bassel, Nabila McCrimmon, Tara Wu, Elwin Chang, Mingway Terlikbayeva, Assel Hunt, Timothy Darisheva, Meruyert Primbetova, Sholpan Davis, Alissa Metsch, Lisa R. Feaster, Daniel J. Baiserkin, Baurzhan Abishev, Asylkhan Denebayeva, Alfiya Sagimbayev, Beibit Kurmetova, Kulpan Mashirov, Kozhakhmet Gilbert, Louisa JAMA Netw Open Original Investigation IMPORTANCE: The increasing HIV incidence rates and suboptimal rates of testing, engagement, and retention in care for people who inject drugs (PWID) in Kazakhstan underscore the need for effective HIV care continuum interventions for PWID. OBJECTIVE: To determine the effectiveness of the Bridge HIV care continuum intervention implemented in needle and syringe programs (NSPs) in Kazakhstan. DESIGN, SETTING, AND PARTICIPANTS: This stepped-wedge cluster trial was conducted from February 2017 to May 2020, with implementation beginning sequentially across 3 cities (Almaty, Karaganda-Temirtau, and Shymkent) in August 2017, January 2018, and May 2019. Intervention effect sizes were estimated via population-averaged models, and hypothesis testing relied on a permutation testing approach. The primary unit of analysis was an NSP. Data analysis was performed from October 2020 to April 2022. INTERVENTIONS: The intervention addresses the full HIV care continuum: identification, testing, referral to services, and linkage to HIV care. The 3 intervention components were (1) a social network strategy, a peer-driven recruitment approach for HIV testing; (2) HIV counseling, rapid testing, and referral following international and national guidelines and protocols; and (3) enhanced antiretroviral treatment and access to services. MAIN OUTCOMES AND MEASURES: The primary outcomes were the effectiveness of implementing Bridge’s enhanced service integration approach in increasing the number of PWID served at NSPs, increasing the number of PWID who are tested for HIV in NSPs, and improving linking HIV-positive PWID with HIV care. Secondary outcomes included numbers of clients registered for HIV care, initiation of antiretroviral therapy, and viral suppression. RESULTS: Twenty-four NSPs (8 in each city) served a total of 1225 PWID (369 in Almaty, 618 in Karaganda-Temirtau, and 238 in Shymkent) at the preimplementation study step; 1015 clients (82.9%) were male, and the mean (SD) age was 36.7 (7.1) years. Compared with preimplementation study steps, during Bridge intervention implementation steps, NSPs experienced a significant increase in the number of PWID clients registered (incidence rate ratio, 2.37; 95% CI, 1.48-3.78) and the number of PWID who received rapid HIV tests (incidence rate ratio, 3.98; 95% CI, 2.30-6.90). No significant increase in referral to HIV care was observed. The study also found significant support for secondary outcomes of antiretroviral therapy initiation and the number of clients who achieved viral suppression. CONCLUSIONS AND RELEVANCE: In this stepped-wedge cluster trial, the findings suggest that implementation of the Bridge intervention was associated with significant improvement in several steps in the continuum of HIV care for PWID in Kazakhstan. TRIAL REGISTRATION: ClinicalTrials.gov Identifier: NCT02796027 American Medical Association 2022-12-01 /pmc/articles/PMC9716389/ /pubmed/36454567 http://dx.doi.org/10.1001/jamanetworkopen.2022.44734 Text en Copyright 2022 El-Bassel N et al. JAMA Network Open. https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the CC-BY License.
spellingShingle Original Investigation
El-Bassel, Nabila
McCrimmon, Tara
Wu, Elwin
Chang, Mingway
Terlikbayeva, Assel
Hunt, Timothy
Darisheva, Meruyert
Primbetova, Sholpan
Davis, Alissa
Metsch, Lisa R.
Feaster, Daniel J.
Baiserkin, Baurzhan
Abishev, Asylkhan
Denebayeva, Alfiya
Sagimbayev, Beibit
Kurmetova, Kulpan
Mashirov, Kozhakhmet
Gilbert, Louisa
Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title_full Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title_fullStr Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title_full_unstemmed Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title_short Effectiveness of an Intervention to Improve HIV Service Delivery for People Who Inject Drugs in Kazakhstan: A Cluster Trial
title_sort effectiveness of an intervention to improve hiv service delivery for people who inject drugs in kazakhstan: a cluster trial
topic Original Investigation
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716389/
https://www.ncbi.nlm.nih.gov/pubmed/36454567
http://dx.doi.org/10.1001/jamanetworkopen.2022.44734
work_keys_str_mv AT elbasselnabila effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT mccrimmontara effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT wuelwin effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT changmingway effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT terlikbayevaassel effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT hunttimothy effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT darishevameruyert effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT primbetovasholpan effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT davisalissa effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT metschlisar effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT feasterdanielj effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT baiserkinbaurzhan effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT abishevasylkhan effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT denebayevaalfiya effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT sagimbayevbeibit effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT kurmetovakulpan effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT mashirovkozhakhmet effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial
AT gilbertlouisa effectivenessofaninterventiontoimprovehivservicedeliveryforpeoplewhoinjectdrugsinkazakhstanaclustertrial